New approaches for precise response evaluation in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

New approaches for precise response evaluation in hepatocellular carcinoma

New approaches for precise response evaluation in hepatocellular carcinoma

http://www.wikidata.org/entity/Q26866367

about

Imaging for assessment of treatment response in hepatocellular carcinoma: Current update.MRI features of hepatocellular carcinoma related to biologic behavior ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma.Transarterial Chemoembolization of Liver Metastases from Uveal Melanoma Using Irinotecan-Loaded Beads: Treatment Response and Complications.

P2860

Q35568722-6AB109AB-3E99-472F-89A8-72F50ADE6D22 Q35619951-F35A255D-2E36-40F0-B510-D26B9038B7FF Q39169884-297AE5C6-2E51-48FE-ACD3-F446627E1BAD Q53017847-27CAAB1A-14C7-499F-BED1-E81CBE2E4E65

P2860

New approaches for precise response evaluation in hepatocellular carcinoma

http://www.wikidata.org/entity/Q26866367

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

New approaches for precise response evaluation in hepatocellular carcinoma

@ast

New approaches for precise response evaluation in hepatocellular carcinoma

@en

New approaches for precise response evaluation in hepatocellular carcinoma

@nl

type

label

New approaches for precise response evaluation in hepatocellular carcinoma

@ast

New approaches for precise response evaluation in hepatocellular carcinoma

@en

New approaches for precise response evaluation in hepatocellular carcinoma

@nl

prefLabel

New approaches for precise response evaluation in hepatocellular carcinoma

@ast

New approaches for precise response evaluation in hepatocellular carcinoma

@en

New approaches for precise response evaluation in hepatocellular carcinoma

@nl

P1433

Q26866367-CB4EE66A-A27C-4098-B4BA-F9749499B00F

P1476

Q26866367-E7F94A49-5F41-4000-83FC-4FFBC98C50AC

P2093

Q26866367-C3B127DC-B081-44A8-B494-5B31098AD6FD

Q26866367-F842DA3B-9BE5-4FBB-932C-5F3301DF5A27

P2860

Q26866367-00066F7C-FB32-4695-8210-C5DD79165C1D

Q26866367-073CB4C6-E4FD-4174-B048-126D03C7F0FF

Q26866367-0A6E94E8-106F-441B-A8E4-1EB7434E2E30

Q26866367-0C9EEC2B-B861-404E-A32A-B7845368F9B0

Q26866367-0F6ACF28-5F13-4A5D-9340-DFBA0B6ADB73

Q26866367-1816B4CB-D086-499A-80D7-ECF02E5478D1

Q26866367-1A4B7EC6-FE0B-4417-AFB8-97F96E6BA4E8

Q26866367-1BB99B03-2E5F-4A5D-BF88-9180021ECFA0

Q26866367-20B63821-2E3E-4D71-83CD-16B37F9501AD

Q26866367-21223604-3A75-4914-8C8A-E8E9ADD5241F

P304

Q26866367-69D76A0E-E821-41F4-94DD-D9E1A68C09E6

P31

Q26866367-F516EC74-FEF1-4601-8C3D-A2D546CE87B3

P356

Q26866367-FDCFCAEB-C666-45D6-9FA3-564C78096C92

P407

Q26866367-A35676CE-7734-4D7F-A56E-009AD9D68582

P433

Q26866367-0DE92F7A-7078-47AD-A692-7CE914F21ADD

P478

Q26866367-70EE1D33-520B-4887-BE36-EA222CFDD1D1

P50

Q26866367-98D38FC3-EE9D-4921-9896-B0F0784BD1A6

P577

Q26866367-3F50E98B-AF2C-4C8B-A9C8-88CA633CBF8D

P5875

Q26866367-E547F8C6-6B29-43B5-9692-E73A6134913C

P698

Q26866367-A83AB06C-C9D7-4C46-995C-FF3E397357EC

P932

Q26866367-360EAEA2-2AC4-4EA8-8B48-7F9228B245C3

P356

WJG.V20.I12.3059

P1433

World Journal of Gastroenterology

P1476

New approaches for precise response evaluation in hepatocellular carcinoma

@en

P2093

Dushyant V Sahani

http://www.w3.org/2001/XMLSchema#string

Koichi Hayano

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Sorafenib in advanced hepatocellular carcinoma

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Reporting results of cancer treatment

Imaging of hepatocellular carcinoma: diagnosis, staging and treatment monitoring

Hepatocellular carcinoma treated with interventional procedures: CT and MRI follow-up

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group.

P304

3059-3068

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I12.3059

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Jorge M Fuentes-Orrego

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261329125

http://www.w3.org/2001/XMLSchema#string

P698

24696594

http://www.w3.org/2001/XMLSchema#string

P932

3964378

http://www.w3.org/2001/XMLSchema#string